Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

Health

Ozempic Drug Fails To Quell Alzheimer’s In Novo Nordisk Trials

By The New York Times

Hopes were high. In retrospect, perhaps too high. On Monday, Novo Nordisk announced that two large studies failed to find any effect of the drug semaglutide on cognition and functioning in people with mild cognitive impairment — an early stage of Alz ...Read more

Related Posts

7 Benefits of The Keto Diet

7 Benefits of The Keto Diet

Dec 30, 2020
College Football Playoff rankings grades, snubs: Texas Tech gets an A+, BYU an F

College Football Playoff rankings grades, snubs: Texas Tech gets an A+, BYU an F

Nov 12, 2025
Tuberculosis kills 1.23 million people last year, WHO says

Tuberculosis kills 1.23 million people last year, WHO says

Nov 13, 2025
Islam Makhachev says loss early in UFC set him up for successful career

Islam Makhachev says loss early in UFC set him up for successful career

Nov 13, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.